The involvement of Fas-Fas ligand pathway in fibrosing lung diseases

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 1, 1999, Pages 53-60

  Kuwano, Kazuyoshi ^a   Miyazaki, Hiroyuki ^a   Hagimoto, Naoki ^a   Kawasaki, Masayuki ^a   Fujita, Masaki ^a   Kunitake, Ritsuko ^a   Kaneko, Yumi ^a   Hara, Nobuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CRYOPRESERVATION; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MALE; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD15; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; CRYOPRESERVATION; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032622244     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.1.2941     Document Type: Article

References (40)

1. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
2. Suda, T., T. Takahashi, T. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
3. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438-441.
4. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444.
5. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. M. Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
6. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
7. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809.
8. Hiramatsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359.
9. Polnovsky, V. A., B. Chen, C. Henke, D. Snover, C. Wendt, D. H. Ingbar, and P. B. Bitterman. 1993. Role of mesenchymal cell death in lung remodeling after injury. J. Clin. Invest. 92:388-397.
10. Liebow, A. 1975. Definition and classification of interstitial pneumonias in human pathology. In Progress in Respiration Research, Vol. 8. F. Baset and R. George, editors. Karger, New York. 1-33.
11. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. (First of two parts.) N. Engl. J. Med. 310:154-166.
12. Wafl/Cipl and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154:477-483.
13. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
14. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K. M. Debatin, P. H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
15. Crystal, R. G., J. D. Fulmer, W. C. Roberts, M. L. Moss, B. R. Line, and H. Y. Reynolds. 1976. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann. Intern. Med. 85:769-788.
16. Wilkinson, M. 1991. Purification of RNA. In Essential Molecular Biology: A Practical Approach, Vol. 1. T. A. Brown, editor. Oxford University Press, New York. 80-81.
17. Hagimoto, N., K. Kuwano, Y. Nomoto, R. Kunitake, and N. Hara. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in beomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 16:91-101.
18. Nuovo, G. J. 1994. PCR In Situ Hybridization: Protocols and Applications, 2nd ed. Raven Press, New York.
19. Shin, R. W., T. Iwaki, T. Kitamoto, and J. Tateishi. 1991. Methods in laboratory investigation. Hydrated autoclave pretreatment enhances TAU. Immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab. Invest. 64:693-702.
20. Weinberger, S. E., J. A. Kelman, N. A. Elson, R. C. Young, H. Y. Reynolds, J. D. Fulmer, and R. G. Crystal. 1978. Bronchoalveolar lavage in interstitial lung disease. Ann. Intern. Med. 89:459-466.
21. Reynolds, H. Y., J. D. Fulmer, J. A. Kazmierowsky, W. C. Roberts, M. M. Frank, and R. G. Crystal. 1977. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumponitis. J. Clin. Invest. 59:165-175.
22. Haslam, P. L., A. Dewar, P. Butchers, Z. S. Primett, A. Newman-Taylor, and M. Turner-Warwick. 1987. Mast cells, atypical lymphocytes and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis: comparison with other interstitial lung diseases. Am. Rev. Respir. Dis. 135:35-47.
23. Kagi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxity. Science 265:528-530.
24. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652.
25. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, and K. Okumura. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364.
26. + T cell-mediated cytotoxicity. J. Immunol. 152:1127-1133.
27. + cytotoxic cells. Proc. Natl. Acad. Sci. USA 91:4185-4189.
28. Conrad-Liles W., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429-440.
29. Hagimoto, N., K. Kuwano, H. Miyazaki, R. Kunitake, M. Fujita, M. Kawasaki, Y. Kaneko, Y. Nomoto, and N. Hara. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-278.
30. Woo, D. 1995. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333:18-25.
31. Mallat, Z., A. Tedgui, F. Fontaliran, R. Frank, M. Durigon, and G. Fontaine. 1996. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N. Engl. J. Med. 335:1190-1196.
32. Narula, J., N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and Ban-An Khaw. 1996. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335: 1182-1189.
33. Khalil, N., R. N. O'Connor, H. W. Unruh, P. W. Warren, K. C. Flanders, A. Kemp, O. H. Bereznay, and A. H. Greenberg. 1991. Increased production and immunohistochemical localization of transforming factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-162.
34. Suzuki, K., T. Ono, and K. Takahashi. 1992. Inhibition of DNA synthesis by TGF-βI coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein. Biochem. Biophys. Res. Commun. 183:1175-1183.
35. Li, C. Y., L. Suardet, and J. B. Little. 1995. Potential role of WAFI/Cipl/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:4971-4974.
36. Tamura, T., N. Aoyama, H. Saya, H. Haga, S. Futami, M. Miyamoto, T. Koh, T. Ariyasu, M. Tachi, M. Kasuga, and R. Takahashi. 1995. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 11:1939-1946.
37. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol. Cell. Biol. 15:3032-3040.
38. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655-663.
39. Miyazaki, Y., K. Araki, C. Vesin, I. Garcia, Y. Kapanci, J. A. Whitsett, P. F. Piguet, and P. Vassalli. 1995. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J. Clin. Invest. 96:250-259.
40. Abreu, M. M., A. Vidrich, D. H. Lynch, and S. R. Targan. 1995. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J. Immunol. 155:4147-4154.